Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes (No)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Wayne State University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Wayne State University
ClinicalTrials.gov Identifier:
NCT00790348
First received: November 12, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
  Purpose

The purpose of this study is to see the effect of Januvia on Ghrelin levels in patients with diabetes.


Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

Resource links provided by NLM:


Further study details as provided by Wayne State University:

Biospecimen Retention:   Samples Without DNA

Serum of patients will be kept for future studies


Estimated Enrollment: 45
Study Start Date: July 2008
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Patients who on Januvia
2
Patients on Janumet (Combination of Januvia and Metformin)
3
Patients on Metformin

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with type 2 diabetes on oral agent that require Metformin or Januvia only

Criteria

Inclusion Criteria:

  • Patients with Type 2 diabetes

Exclusion Criteria:

  • Renal failure
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00790348

Locations
United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48201
Contact: Berhane Seyoum, MD    313-745-4008    bseyoum@med.wayne.edu   
Principal Investigator: Berhane Seyoum, MD, MPH         
Sponsors and Collaborators
Wayne State University
  More Information

No publications provided

Responsible Party: Berhane Seyoum, Wayne State University
ClinicalTrials.gov Identifier: NCT00790348     History of Changes
Other Study ID Numbers: 0709005250
Study First Received: November 12, 2008
Last Updated: November 12, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 21, 2014